39 results on '"Aeder, Mark I."'
Search Results
2. Simultaneous Liver-Kidney Transplantation: Policy Update and the Challenges Ahead
3. Thirty-day readmission after ventral hernia repair: predictable or preventable?
4. Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis
5. The risk for Chagasʼ disease in the Midwestern United States organ donor population is low
6. ABO blood group influences a candidateʼs likelihood of receiving an HLA zero antigen mismatch kidney
7. HLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors
8. Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates
9. Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System?
10. The influence of age, gender and ethnicity on cadaveric organ recovery rate
11. Improved Graft Survival in Cadaveric Renal Retransplantation by Flow Crossmatching
12. Thirty-day readmission after ventral hernia repair: predictable or preventable?
13. Hemodialysis Vintage, Black Ethnicity, and Pretransplantation Antidonor Cellular Immunity in Kidney Transplant Recipients
14. Improved Renal Function after Conversion from Tacrolimus/Sirolimus to Tacrolimus/Mycophenolate Mofetil in Kidney Transplant Recipients
15. Differences in Patient and Transplant Professional Perceptions of Immunosuppression-Induced Cosmetic Side Effects
16. Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System?
17. COLD ISCHEMIA TIME: AN INDEPENDENT PREDICTOR OF INCREASED HLA CLASS I ANTIBODY PRODUCTION AFTER REJECTION OF A PRIMARY CADAVERIC RENAL ALLOGRAFT1
18. EFFECT OF DONOR BRAIN DEATH DURATION ON GRAFT OUTCOME.
19. TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS1
20. LONG-TERM GRAFT SURVIVAL IS IMPROVED IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING1
21. INFLUENCE OF THE Rh (D) BLOOD GROUP SYSTEM ON GRAFT SURVIVAL IN RENAL TRANSPLANTATION
22. TEN-YEAR EXPERIENCE IN TRANSPLANTATION OF A2KIDNEYS INTO B AND O RECIPIENTS1
23. DETECTION OF HLA IgG ANTIBODIES BY TWO ENZYME-LINKED IMMUNOASSAYS, SOLUBILIZED HLA CLASS I AND PRA-STAT
24. INABILITY TO PREDICT POSITIVE CROSS-MATCHES UNDERSCORES THE NEED FOR HISTOCOMPATIBILITY EXPERTISE IN PAIRED DONATION PROGRAMS (PDP).
25. COLD ISCHEMIA TIME: AN INDEPENDENT PREDICTOR OF INCREASED HLA CLASS I ANTIBODY PRODUCTION AFTER REJECTION OF A PRIMARY CADAVERIC RENAL ALLOGRAFT1.
26. TEN-YEAR EXPERIENCE IN TRANSPLANTATION OF A2KIDNEYS INTO B AND O RECIPIENTS.
27. HLA-DR AND DQ TYPING BY POLYMERASE CHAIN REACTION USING SEQUENCE-SPECIFIC PRIMER MIXES REDUCES THE INCIDENCE OF PHENOTYPIC HOMOZYGOSITY (BLANKS) OVER SEROLOGY.
28. Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2Kidneys: Time for a New National System?
29. TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2AND A2B KIDNEYS1
30. Role of Surgical and Percutaneous Drainage in the Treatment of Abdominal Abscesses
31. RAPID INFUSION OF INTRAVENOUS FLUIDS
32. Technical limitations in the rapid infusion of intravenous fluids
33. A CLINICALLY PROVEN, WEB-BASED, KIDNEY PAIRED DONATION REGISTRY.
34. TOWARDS INDIVIDUALIZED TREATMENT OF KIDNEY TRANSPLANT RECIPIENTS: PRETRANSPLANT ANTI DONOR CELLULAR IMMUNITY BY IFN-γ ELISPOT IDENTIFIES CANDIDATES THAT CAN MOST BENEFIT FROM INDUCTION THERAPY.
35. DECREASED ALBUMIN EXCRETION AFTER CONVERSION FROM SIROLIMUS TO ENTERIC-COATED MYCOPHENOLIC SODIUM IN PATIENTS MAINTAINED ON CNI THERAPY.
36. EXPECTIONS FOR SUCCESSFUL MATCHING IN A PAIRED DONATION CONSORTIUM (PDC): EFFECT OF ABO AND SENSITIZATION.
37. SURVIVAL AND FUNCTION OF ZER0 ANTIGEN MISMATCHED (0MM) KIDNEYS: IS HLA THE PRIMARY DETERMINANT?
38. TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS.
39. DETECTION OF HLA IgG ANTIBODIES BY TWO ENZYMELINKED IMMUNOASSAYS, SOLUBILIZED HLA CLASS I AND PRASTAT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.